Does Structured Reporting Improve Lung Cancer Reports? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Does Structured Reporting Improve Lung Cancer Reports?

A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.

  • By

  • Andrea Surnit

  • July 2, 2026

  • 3 min

Share

Clinical Scorecard: Does Structured Reporting Improve Lung Cancer Reports?

At a Glance

CategoryDetail
ConditionLung Cancer Pathology Reporting
Key MechanismsStructured reporting tool enhances report completeness and accuracy.
Target PopulationPathologists and lung cancer patients undergoing resection.
Care SettingPathology diagnostics in oncology.

Key Highlights

  • Structured reporting achieved 99.9% completeness in pathology reports.
  • 90% adoption rate among pathologists during prospective implementation.
  • Identified 33 missing or inconsistent data elements in retrospective reports.
  • Automated tumor-node-metastasis staging detected classification errors.
  • Feedback indicated value in automated completeness checks and dynamic data display.

Guideline-Based Recommendations

Diagnosis

  • Utilize structured reporting tools to enhance completeness of pathology reports.

Management

  • Incorporate structured reporting into routine diagnostics for lung cancer.

Monitoring & Follow-up

  • Assess the integration of structured reporting with existing laboratory information systems.

Risks

  • Limited generalizability due to single institution study and focus on lung cancer resection specimens.

Patient & Prescribing Data

Patients undergoing lung cancer resection.

Structured reporting may lead to more accurate and complete pathology reports.

Clinical Best Practices

  • Adopt structured reporting to improve pathology report quality.
  • Encourage feedback from pathologists to enhance workflow integration.

Related Resources & Content

Original Source(s)

Does Structured Reporting Improve Lung Cancer Reports?

  • by Andrea Surnit

  • July 2, 2026

Related Content

Triple-positive profile may flag adverse prostate cancer pathology

A combination of PSA density, MRI, and PSMA PET findings identified a small subgroup with adverse pathology, supporting further study of biopsy-sparing pathways.

FDA expands bladder cancer therapy approval

The expansion offers another treatment option for patients with high-grade tumors following BCG failure.

AI cuts lesion measurement time by 34%

Automated lesion measurements increased agreement on treatment response, although expert-generated proposals were accepted more often and required fewer adjustments.